Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | PTGES | O14684 | 4/20 | 0.84 |
| ▸ | CRYAB | P02511 | 2/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | FNTA | P49354 | 1/20 | 0.69 |
| ▸ | FNTB | P49356 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.60 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.60 |
| ▸ | PREP | P48147 | 1/20 | 0.59 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.59 |
| ▸ | BACE1 | P56817 | 1/20 | 0.56 |
| ▸ | CRYAA | P02489 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19194140 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL17431708 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL6130526 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL415761 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL5666302 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL2340127 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL20990912 | 0.92 | MAPT (0.85) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL4735043 | 0.92 | MAPT (0.85) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL21183478 | 0.92 | MAPT (0.85) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL21149075 | 0.92 | MAPT (0.85) | MAPTUSP2ALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 459 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1451132-A4 | CHEMICAL SYNTHESIS | UNIV WAIKATO (NZ) | 2006-02-08 | — | — | EP | claimed |
| US-20050038301-A1 | Producing vicinal diols; reacting with hydroxyl group donor and reducing acidic agent | UNIVERSITY OF WAIKATO, THE (NZ) | 2005-02-17 | — | — | US | claimed |
| EP-1451132-A1 | CHEMICAL SYNTHESIS | THE UNIVERSITY OF WAIKATO (NZ) | 2004-09-01 | — | — | EP | claimed |
| WO-2003040066-A1 | CHEMICAL SYNTHESIS | THE UNIVERSITY OF WAIKATO (NZ) | 2003-05-15 | — | — | WO | claimed |
| US-6315981-B1 | USED FOR OBTAINING IMAGE OF AN INTERNAL REGION OF HUMANS | IMARX THERAPEUTICS, INC. | 2001-11-13 | — | — | US | claimed |
| EP-0760684-A4 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2000-03-15 | — | — | EP | claimed |
| EP-0740528-A4 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP (US) | 1998-04-01 | — | — | EP | claimed |
| US-5733572-A | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles | IMARX PHARMACEUTICAL CORP. (US) | 1998-03-31 | — | — | US | claimed |
| JP-H10500692-A | — | — | 1998-01-20 | — | — | JP | claimed |
| EP-0797433-A4 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 1997-12-03 | — | — | EP | claimed |
| EP-0797433-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | ImaRx Pharmaceutical Corp. (US) | 1997-10-01 | — | — | EP | claimed |
| EP-0760684-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1997-03-12 | — | — | EP | claimed |
| EP-0740528-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1996-11-06 | — | — | EP | claimed |
| WO-1995032006-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX, PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | claimed |
| WO-1995024184-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | UNGER EVAN C (US) | 1995-09-14 | — | — | WO | claimed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | claimed |
| US-12427208-B2 | Iodinated phenolic lipids and methods and cosolvent systems for iodination of phenolic lipids | UNIVERSITY OF CINCINNATI (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250295806-A1 | IMMUNOSTIMULATORY NANOPARTICLE | UNIV CASE WESTERN RESERVE (US) | 2025-09-25 | — | — | US | disclosed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | disclosed |
| US-4684479-A | Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures | CAVITATION-CONTROL TECHNOLOGY, INC. | 1987-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427208-B2 | Iodinated phenolic lipids and methods and cosolvent systems for iodination of phenolic lipids | FABP4, LCAT, HDLBP | MAPT 2158/4885USP2 2851/4885ALDH1A1 2532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.